All News

Autologous

The Impact of AI & Sensor-Based Cell Manufacturing on Price & Availability of Cell Therapy
9 January 2023
The Impact of AI & Sensor-Based Cell Manufacturing on Price & Availability of Cell Therapy
In this interview, Ohad Karnieli,
Mind the Gap: Transforming Cell & Gene Therapies from Scientific Success to Available Cures
29 August 2022
Mind the Gap: Transforming Cell & Gene Therapies from Scientific Success to Available Cures
Ohad Karnieli, Founder and CEO
New Technologies for Cell Therapy Manufacturing with Invetech
26 August 2022
New Technologies for Cell Therapy Manufacturing with Invetech
David Hodl, Head of Business
Pain Points to Optimising Automated Manufacturing Transitions
7 February 2022
Pain Points to Optimising Automated Manufacturing Transitions
Event Report
POPULAR NEWS ITEMS
Image
23 March 2023

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image
14 March 2023

Pfizer Invests $43 Billion to Acquire Seagen

Image
2 March 2023

Early Adoption and Partnerships – The Secret to Commercialization Success?

Developing Compliant Systems to Modernise the Cell Therapy Manufacturing Workflow
19 January 2022
Developing Compliant Systems to Modernise the Cell Therapy Manufacturing Workflow
Interview - Q&A
Scalability & Decentralised Manufacture Vs Comparability and Potency Assays: Pain Points and Opportunities
19 October 2021
Scalability & Decentralised Manufacture Vs Comparability and Potency Assays: Pain Points and Opportunities
Event Report
Automating Release for Autologous Products
8 August 2021
Automating Release for Autologous Products
Point of Care CAR-T with Adva Biotechnologies
1 July 2021
Point of Care CAR-T with Adva Biotechnologies
Watch as Ohad introduces the
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image

Pfizer Invests $43 Billion to Acquire Seagen

Image

Early Adoption and Partnerships – The Secret to Commercialization Success?